PUBLIC CONTRACT · 2023

Vários Medicamentos

Contract value: €105,035.69
Signed on: 15 March 2023
Procedure: Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 9876384

PUBLISHED DESCRIPTION

61002123 - AQ Urgente Medicamentos

WHO CONTRACTED

Parties involved

Contracting body: Centro Hospitalar de Setúbal, E. P. E.
Awardee: BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL; - - LABORATORIOS URGO, S.L.U.; ZAMBON - PRODUTOS FARMACEUTICOS, LDA; CELGENE SOCIEDADE UNIPESSOAL, LDA; MYLAN, LDA.; TEOFARMA, SRL; GENERIS - FARMACEUTICA, S.A.; KRKA FARMACEUTICA; TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA; Boehringer Ingelheim Portugal; ARTUR SALGADO, S.A.; DANONE NUTRICIA, UNIPESSOAL,LDA; SANDOZ FARMACÊUTICA, LDA.; ABBOTT LABORATORIOS, LDA; VIFOR PHARMA PORTUGAL, SA; ACCORD HEALTHCARE , UNIPESSOAL LDA; FRESENIUS KABI PHARMA PORTUGAL; ABBVIE,LDA; ALFASIGMA PORTUGAL, LDA; OVERPHARMA - PROD. MÉDICOS E FARMACÊUTICOS, LDA.; KVTECH PORTUGAL -PRODUTOS MEDICOS, UNIPESSOAL,LDA.; PERRIGO PORTUGAL, LDA (EX. OMEGA); OFTALDATA - PROD. OFTALMOLOGIA, LDA.; TAKEDA FARMACEUTICOS PORTUGAL, LDA (SHIRE)
Place of performance: Portugal, Setúbal, Setúbal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: BIOGEN PORTUGAL, SOC FARMACÊUTICA, UNIPESSOAL · Tax ID 506415740
Awardee: - - LABORATORIOS URGO, S.L.U.
Awardee: ZAMBON - PRODUTOS FARMACEUTICOS, LDA · Tax ID 502155930
Awardee: CELGENE SOCIEDADE UNIPESSOAL, LDA · Tax ID 507791690
Awardee: MYLAN, LDA. · Tax ID 502248793
Awardee: TEOFARMA, SRL · Tax ID 980244463
Awardee: GENERIS - FARMACEUTICA, S.A. · Tax ID 508107997
Awardee: KRKA FARMACEUTICA · Tax ID 507981227
Awardee: TEVA PHARMA - PRODUTOS FARMACEUTICOS,LDA · Tax ID 507045491
Awardee: Boehringer Ingelheim Portugal · Tax ID 500537410
Awardee: ARTUR SALGADO, S.A. · Tax ID 503612600
Awardee: DANONE NUTRICIA, UNIPESSOAL,LDA · Tax ID 507558286
Awardee: SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Awardee: ABBOTT LABORATORIOS, LDA · Tax ID 500006148
Awardee: VIFOR PHARMA PORTUGAL, SA · Tax ID 516677586
Awardee: ACCORD HEALTHCARE , UNIPESSOAL LDA · Tax ID 508622263
Awardee: FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
Awardee: ABBVIE,LDA · Tax ID 510229050
Awardee: ALFASIGMA PORTUGAL, LDA · Tax ID 502857722
Awardee: OVERPHARMA - PROD. MÉDICOS E FARMACÊUTICOS, LDA. · Tax ID 505792362
Awardee: KVTECH PORTUGAL -PRODUTOS MEDICOS, UNIPESSOAL,LDA. · Tax ID 508671531
Awardee: PERRIGO PORTUGAL, LDA (EX. OMEGA) · Tax ID 506112233
Awardee: OFTALDATA - PROD. OFTALMOLOGIA, LDA. · Tax ID 504887459
Awardee: TAKEDA FARMACEUTICOS PORTUGAL, LDA (SHIRE) · Tax ID 502801204

Matches in the records

MYLAN, LDA. and VIFOR PHARMA PORTUGAL, SA share an address · Source: TED (Jornal Oficial da UE), aviso 604352-2025 · Source: TED (Jornal Oficial da UE), aviso 349614-2026

Address and group matches come from the records cited and say only what those records show.

HOW MUCH AND WHEN

Values and timeline

Contract price: €105,035.69
Procedure base price: €105,035.69
Total effective price: Not reported on Portal BASE
Publication date: 22 March 2023
Award date: 15 March 2023
Signing date: 15 March 2023
Performance period: 12 days

The contract price is the value agreed in the contract, not the amount paid.

HOW IT WAS CONTRACTED

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion: Monofator
CPV code: 33000000-0 - Equipamento médico, medicamentos e produtos para cuidados pessoais
Legal basis: Artigo 259.º do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement: CP 2020/18 - Medicamentos do grupo 4: sangue
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 6406318

KEEP EXPLORING

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts